Get the StoQuant digest — free

Free StoQuant digest by email. No account needed. See today's research picks.

Subscribe free

MESO vs PHVS — Stock Comparison

Compare MESO and PHVS side-by-side on StoQuant: MESO Q-Score 45 vs PHVS 44; analyst signal 65 vs 84. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.

Side-by-side snapshot

• MESO — Mesoblast Limited · Health Care · market cap $1.59B · Q-Score verdict Hold (45.0, grade C) · analyst signal 65/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 43/100, technicals 34/100. Full MESO research.
• PHVS — Pharvaris N.V. · Health Care · market cap $2.19B · Q-Score verdict Hold (44.0, grade C) · analyst signal 84/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 97/100, valuation 74/100 · weakest signals: technicals 59/100. Full PHVS research.

What you can compare

• Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
• Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
• Insider activity: Cluster scores and recent Form 4 buying.
• Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
• Strategic edges: Competitive moat and durable advantage analysis.
• Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
• Macro context: Market regime and sector rotation alignment.

Deep dive: MESO research · PHVS research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →